Dr. Dhir on Diagnostic Challenges in Sarcoma

Video

In Partnership With:

Aditi Dhir, MD, discusses the challenges of diagnosing patients with sarcoma.

Aditi Dhir, MD, clinical assistant professor, Department of Pediatrics, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses the challenges of diagnosing patients with sarcoma.

Although many sarcomas are aggressive, they can be slow growing because they are rooted in deeper tissues, says Dhir. As such, the average time to diagnose sarcoma ranges from a few months to 1 year, depending on the tumor location and associated symptoms, Dhir explains.

Notably, when a sarcoma diagnosis is confirmed, it is important to obtain a core biopsy rather than an excisional biopsy. Core biopsies can shed light on the true extent of the disease and minimize the risk of incomplete resection or positive surgical margins, which can influence treatment, concludes Dhir.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute